3.61
-0.04(-1.10%)
Currency In USD
| Previous Close | 3.65 |
| Open | 3.66 |
| Day High | 3.74 |
| Day Low | 3.61 |
| 52-Week High | 5.22 |
| 52-Week Low | 1 |
| Volume | 141,877 |
| Average Volume | 237,585 |
| Market Cap | 86.46M |
| PE | -1.37 |
| EPS | -2.64 |
| Moving Average 50 Days | 2.66 |
| Moving Average 200 Days | 2.17 |
| Change | -0.04 |
If you invested $1000 in Celularity Inc. (CELU) since IPO date, it would be worth $36.84 as of August 22, 2025 at a share price of $3.61. Whereas If you bought $1000 worth of Celularity Inc. (CELU) shares 5 years ago, it would be worth $34.88 as of August 22, 2025 at a share price of $3.61.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Celularity Completes Major Balance Sheet Restructuring, Retires All $41.6 Million in Senior Secured Debt
GlobeNewswire Inc.
Aug 18, 2025 12:00 PM GMT
Retired all principal and accrued interest owed its two senior secured lenders, Resorts World Inc. Pte. Ltd., or RWI, and C.V. Starr and Co., Inc., eliminating all senior secured debt from its balance sheet.Entered into an Asset Purchase Agreement wi
Celularity & Fountain Life Announce Partnership to Deliver Stem Cell Therapies Under New Florida Law
GlobeNewswire Inc.
Jul 09, 2025 12:30 PM GMT
Fountain Life operates four flagship longevity centers, including two in Florida, where a new state law effective July 1, 2025, authorizes licensed physicians to administer stem cell therapies to members with conditions in orthopedics, wound care, an
Celularity Hails New Florida Law Opening Patient Access to Stem Cell Therapies
GlobeNewswire Inc.
Jul 01, 2025 12:30 PM GMT
New law goes into effect on July 1st authorizing Florida physicians to provide stem cell therapies to their patients for orthopedics, wound care, and pain management FLORHAM PARK, N.J., July 01, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CE